Collaborative Addiction Research in Asian Populations Home and Abroad Gavin Bart, MD PhD FACP FASAM Director, Division of Addiction Medicine Department.

Slides:

Advertisements

Similar presentations

Welcome to P REVENTING C LINICIAN B URNOUT : PERSONAL AND P ROFESSIONAL ISSUES AND P LANS Presented by: Mark Linzer, MD, FACP The presentation will begin.

Advertisements

Building Connections for Individuals with Behavioral Health Conditions in the Justice System A. Kathryn Power, M.Ed., Director SAMHSA’s Center for Mental.

Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and.

Project Engage Basha Silverman, Director of Prevention and Advocacy, Brandywine Counseling and Community Services Terry Horton, MD, FACP Chief, Division.

Buprenorphine Treatment: Care Coordination Indications and Options James Schuster, MD, MBA Chief Medical Officer Community Care.

The Impact of Telepsychiatry for Patients with Co-morbid Disorders at a Rural County-Run Residential Treatment Clinic Presented at: Addiction Health Services.

Addiction Medicine Education, Patient Care and Research Update Alex Walley, MD, MSc Clinical Addiction Research and Education (CARE)

Public Health Informatics Conference Nedra Garrett Associate Director for Informatics March 12, 2014 Center for Surveillance, Epidemiology, and Laboratory.

University of Utah Department of Human Genetics The New Science of Addiction Louisa A. Stark, Ph.D. Director.

Antisocial Personality Disorder Karin Neufeld, MD MPH Addiction Treatment Services Department of Psychiatry Johns Hopkins University School of Medicine.

Welcome, Agenda, Challenges and Potential Solutions Implementing Evidence-Based Practices and Performance Measures for Massachusetts Mental Health Services:

Pediatric Behavioral Epidemiology Xinguang (Jim) Chen, MD, PhD Pediatric Prevention Research Center

Personalized Medicine in the Era of Genomics Wylie Burke MD PhD Department of Medical History and Ethics Center for Genomics and Healthcare Equality University.

HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program.

Methadone in Opioid Addiction David Kan, M.D. University of California San Francisco VA Medical Center San Francisco.

A Real World Approach to Treating Tobacco Use in Mental Health Settings Jill Williams, MD Associate Professor of Psychiatry and Director of the Division.

Recovery Centers of King County Buprenorphine Treatment Program AAP Providers Conference, April 19, 2013, Lynnwood, WA Patricia C. Knox, Ph.D.

American Psychiatric Association SAMHSA Minority Fellowship Program (MFP) Annelle B. Primm, M.D., MPH, Program Director Marilyn King, Assistant Program.

2 AMERIGROUP Community Care Entered Maryland market in 1999 Largest MCO in Maryland Serving over 143,000 members in Baltimore City and 20 counties in.

Health Disparities & Resources: Connecting the Community to Care Robert Gilchick, MD, MPH, FACPM Director, Child and Adolescent Health Program and Policy.

Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.

Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective Marek C. Chawarski Yale University School of Medicine.

New Pathways, New Connections: Tobacco and Behavioral Health Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention National Conference.

1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.

Sarah E. Cavanaugh Addiction Therapy-2014 Chicago, USA August 4 - 6, 2014.

Evaluating the Effectiveness of the CTRC: Designing Quantitative and Qualitative Measures to Assess in Real Time the Value of the Center Mike Conlon, University.

Overview of NIDA Funding Opportunities and Grant Funding Tips Bethany Griffin Deeds, Ph.D., M.A. Deputy Chief, Epidemiology Research Branch Division of.

Thailand is located at the Golden Triangle: Population: 65 millions Current Status of Drug Use and HIV in Thailand Apinun Aramrattana, MD, PhD Faculty.

Economic Value of Family Caregiving: 2004 Peter S. Arno, PhD Department of Epidemiology and Population Health Montefiore Medical Center Albert Einstein.

Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University Health Economics and Epidemiology Research Office July.

Marion County Women’s Health Issues Virginia A. Caine, M.D. Director, Marion County Public Health Department Associate Professor, Indiana University School.

WPA Educational Programme on Depressive Disorders Volume One: Fundamentals Copyright © World Psychiatric Association.

State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.

Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.

Integrating Substance Use Treatment into Primary Care: You can do it! Aaron Fox, MD, MS, Assistant Professor of Medicine Albert Einstein College of Medicine/Montefiore.

Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.

Prediction research Introduction and examples A. Cecile J.W. Janssens, PhD Professor of Translational Epidemiology.

Los Angles LGBT Center Noah Kaplan MSW Alex Adame MSW.

Behavioral Health INTEGRATION Recent literature, conceptual frameworks & options for next steps October 16, 2013 Mark Gibson Director Center for Evidence-based.

Promoting Mental Health Care in Taiwan-Policy and practice developments Happy Tan, MD MPH MHS Director, Mental Health Office, DOH Superintendent, Taoyuan.

Persons with Serious Mental Illness Michael B. Blank, PhD Center for Mental Health Policy and Services Research University of Pennsylvania HIV Screening.

PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.

Integrating Program Innovation to Improve Prevention and Care Services USCA 2016 – September 17, 2016 April Stubbs-Smith, MPH Director, Division of Domestic.

Center for Studies of Addiction, University of Pennsylvania, USA

Deadly trio: mental health – HIV - drugs

Some epidemiological principles and methods

The Highs and Lows of Relapse and Recovery in Opioid Use Disorder

Integrating HIV, TB and Addiction Treatment in Malaysian Prisons

Precision Medicine, Community Engagement, and Native Health

screening, brief intervention and referral to treatment

Capacity to screen and treat mental health and substance use disorders at HIV treatment sites in low- and middle-income countries Angela Parcesepe1,2,

Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald

OPIOID ADDICTION AND TREATMENT STAKEHOLDER MEETING

McLean Hospital Division of Alcohol and Drug Abuse

Nathan D. Culver, Pharm.D., BCPS; Hera Saleem, Student Pharmacist;

Leading in Difficult Times: Build It and They Will Come

Substance Use Disorders in People Living with HIV

6th Annual Residential Substance Abuse Treatment Conference

Health Services Research Postdoctoral Fellowship

Developing and Using a Referral Network

Receipt of Medication Treatment after Nonfatal Overdose Among Emerging Adults Sarah M. Bagley, MD, MSc Assistant Professor of Medicine and Pediatrics,

Using Technology to Expand Access to Evidence-Based Therapy

The HIV Epidemic among People who Inject Drugs

Gambling in adolescents: Potential for intervention

Patterns, predictors, and consequences of non-medical use prescription opioids in the Veterans Aging Cohort Study Brandon DL Marshall, PhD Manning Assistant.

Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic

Patient-Centered Clinical Method

Gender Issues and Addiction

No conflicts of interest

Can be personalized to individual group needs.

Presentation transcript:

Collaborative Addiction Research in Asian Populations Home and Abroad Gavin Bart, MD PhD FACP FASAM Director, Division of Addiction Medicine Department of Medicine Hennepin County Medical Center Associate Professor of Medicine University of Minnesota International Conference on Global Health: Prevention and Treatment of Substance Use Disorders and HIV Taipei, Taiwan April 18, 2013

Hmong and opiate dependence Validate the assessment tool –MINI versus SSADDA Prevalence –Laos ~ 10% –Thailand ~15% –US ~3% Mode –Smoking opium –Smoking heroin Malison 2011; Westermeyer 1981, 1995; Wiewel 2005

Hmong entering treatment Westermeyer and Chitasombat 1996

Methadone maintained Hmong: psychiatric comorbidity Bart 2013

Hmong treatment outcome Behavioral only ~90% relapse Methadone ~80% retention –Hmong 49.0 mg (17.4) –Non-Hmong 77.1 mg (25.1) Bart 2012

Hmong: a pocket of people Listman et al, 2007 and unpublished data

Hmong genotype v. phenotype Straka et al. 2006

R-methadone population pharmacokinetics: Hmong and non-Hmong Bart 2013

More questions Why are the Hmong different? –Diet –Transporter function –Genetics Can we predict methadone dose requirements? Does this happen with other medications?

Why Research? To find cures to disease and illness Describe the situation –Epidemiology –Cohort studies Compare approaches –Outcome –Quality of life / Satisfaction –Cost-effective To inform policy

Research resources

Thank You NIDA K23 DA SAMHSA PEPFAR USAID CDC Vietnam VAAC FHI360 Yih-Ing Hser Betty Tai NIDA R13DA035084